Relationship between increased serum neurofilament light chain and glial fibrillary acidic protein levels with non‐motor symptoms in patients with Parkinson's disease

Peixiao Yin,Xuebin Niu,Chenyang Guan,Zixuan Zhang,Yuning Liu,Jinyu Li,Guiyun Cui,Kun Zan,Chuanying Xu
DOI: https://doi.org/10.1111/psyg.13088
2024-02-11
Psychogeriatrics
Abstract:Background This study set out to investigate the relationship between serum neurofilament light chain (NFL), glial fibrillary acidic protein (GFAP), and various non‐motor symptoms (NMSs) in patients with Parkinson's disease (PD). Methods The study included 37 healthy controls (HCs) and 51 PD patients. Clinical assessments of PD symptoms were conducted for all PD patients. The NMSS was utilised to evaluate the NMS burden (NMSB) in individuals. Based on the severity of NMSB, we further categorised the PD group into two subgroups: mild–moderate NMSB group and severe–very severe NMSB group. The amounts of NFL and GFAP in the serum were measured using an extremely sensitive single molecule array (Simoa) method. Statistical analyses were performed on the collected data using SPSS 26.0 and R (version 3.6.3). Results Serum GFAP and NFL levels in the PD group with severe–very severe NMSB were significantly higher than those in the mild–moderate NMSB group (GFAP: P
psychiatry,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?